L D Mayer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

L D Mayer

Showing results (71-80 of 76) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 76 results.

Leukemia Research|July 31, 2012

Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemiaE J Feldman, J E Kolitz, J M Trang, et al.

Biochimica Et Biophysica Acta|June 22, 1988

Characterization of cholesterol hemisuccinate and alpha-tocopherol hemisuccinate vesiclesA S Janoff, C L Kurtz, R L Jablonski, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999

Phase I study of liposomal vincristineK A Gelmon, A Tolcher, A R Diab, et al.

Chemistry and Physics of Lipids|March 1, 1990

The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a surveyT D Madden, P R Harrigan, L C Tai, et al.

Cancer Research|June 13, 2000

Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistanceM J Newman, J C Rodarte, K D Benbatoul, et al.

Bioscience Reports|November 14, 2002

Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)C Allen, N Dos Santos, R Gallagher, et al.

Pageof 8

Search research articles

Showing results (71-80 of 76) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 76 results.

Leukemia Research|July 31, 2012

Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemiaE J Feldman, J E Kolitz, J M Trang, et al.

Biochimica Et Biophysica Acta|June 22, 1988

Characterization of cholesterol hemisuccinate and alpha-tocopherol hemisuccinate vesiclesA S Janoff, C L Kurtz, R L Jablonski, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999

Phase I study of liposomal vincristineK A Gelmon, A Tolcher, A R Diab, et al.

Chemistry and Physics of Lipids|March 1, 1990

The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a surveyT D Madden, P R Harrigan, L C Tai, et al.

Cancer Research|June 13, 2000

Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistanceM J Newman, J C Rodarte, K D Benbatoul, et al.

Bioscience Reports|November 14, 2002

Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)C Allen, N Dos Santos, R Gallagher, et al.

Pageof 8